BR100 Increased By (0.01%)
BR30 Increased By (0.53%)
KSE100 Increased By (0.28%)
KSE30 Increased By (0.29%)
AGHA 6.38 Increased By ▲ 0.06 (0.95%)
BECO 4.35 Increased By ▲ 0.08 (1.87%)
BML 62.55 Increased By ▲ 0.10 (0.16%)
BOP 31.39 Increased By ▲ 0.16 (0.51%)
CNERGY 11.73 Increased By ▲ 0.14 (1.21%)
CSIL 5.91 Increased By ▲ 0.19 (3.32%)
FCCL 61.71 Increased By ▲ 0.17 (0.28%)
FFL 14.79 Decreased By ▼ -0.23 (-1.53%)
FNEL 1.24 Increased By ▲ 0.01 (0.81%)
KEL 6.32 Increased By ▲ 0.06 (0.96%)
KOSM 5.90 Increased By ▲ 0.34 (6.12%)
LOTCHEM 24.69 Increased By ▲ 0.01 (0.04%)
MLCF 103.93 Decreased By ▼ -0.15 (-0.14%)
NBP 173.32 Decreased By ▼ -1.96 (-1.12%)
NCPL 51.83 Decreased By ▼ -0.94 (-1.78%)
NPL 54.03 Decreased By ▼ -0.09 (-0.17%)
OGDC 315.87 Increased By ▲ 2.48 (0.79%)
PACE 9.26 Increased By ▲ 0.06 (0.65%)
PAEL 35.58 Decreased By ▼ -0.22 (-0.61%)
PIBTL 13.66 Increased By ▲ 0.19 (1.41%)
PPL 226.07 Increased By ▲ 4.26 (1.92%)
PRL 80.28 Increased By ▲ 1.20 (1.52%)
PTC 46.64 Decreased By ▼ -0.21 (-0.45%)
SSGC 23.82 Decreased By ▼ -0.05 (-0.21%)
TBL 9.24 Decreased By ▼ -0.07 (-0.75%)
TELE 7.55 Increased By ▲ 0.16 (2.17%)
TPL 24.54 Decreased By ▼ -0.57 (-2.27%)
TPLP 12.99 Increased By ▲ 0.48 (3.84%)
TREET 25.98 Decreased By ▼ -0.27 (-1.03%)
TRG 53.33 Decreased By ▼ -0.11 (-0.21%)
Topic

CureVac

European shares slip

European shares slip

Published 18 Jun, 2021 04:16am
AMSTERDAM/LONDON: European shares fell from record highs on Thursday, tracking declines on Wall Street after the...
CureVac starts review process in Switzerland for COVID-19 vaccine hopeful

CureVac starts review process in Switzerland for COVID-19 vaccine hopeful

Published 19 Apr, 2021 06:10pm
  • Switzerland, which to date has approved COVID-19 shots from Pfizer, Moderna and Johnson & Johnson, has placed orders for five million doses of CureVac's vaccine. It is a so-called mRNA vaccine, like those from Moderna and Pfizer that are already on the market.
  • "The duration of the rolling review will depend on the completeness of the data submitted by CureVac and the results of the clinical trials, and cannot therefore be predicted," Swissmedic said.
CureVac says interest in its COVID-19 vaccine on the rise

CureVac says interest in its COVID-19 vaccine on the rise

Updated 15 Apr, 2021 07:25pm
  • The European Union in November secured up to 405 million doses of CureVac's two-shot vaccine, which has yet to win regulatory approval, the company's only large supply contract so far.
  • Europe's choppy vaccine rollout hit more trouble this week after J&J suspended shipments of its COVID-19 shot and Denmark said it would drop a similar vaccine from AstraZeneca over very rare cases of blood clotting.
EU approves Johnson & Johnson Covid vaccine

EU approves Johnson & Johnson Covid vaccine

Published 12 Mar, 2021 10:12am
  • The EU has so far approved three vaccines -- Pfizer-BioNTech, Moderna and AstraZeneca-Oxford. Three other vaccines are under "rolling review" by the Amsterdam-based EMA -- Novavax, CureVac and Russia's Sputnik.
Latest on worldwide spread of the coronavirus

Latest on worldwide spread of the coronavirus

Published 18 Jan, 2021 10:26am
  • Portugal's public health system is on the verge of collapsing as hospitals in the areas worst-affected by a worrying surge in coronavirus cases are quickly running out of intensive care beds to treat COVID-19 patients.
Germany secured 50mn vaccine doses from CureVac, BioNTech on top of EU supplies

Germany secured 50mn vaccine doses from CureVac, BioNTech on top of EU supplies

Published 08 Jan, 2021 08:17pm
  • The ministry official, speaking on condition of anonymity, said Germany signed a memorandum of understanding with CureVac on Aug. 31 for the supply of 20 million doses of its vaccine under development.
  • The internal health ministry document dated Jan. 7 and seen by Reuters had the same figures.
Loading...